DrugPatentWatch Database Preview
Sagent Pharms Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has forty-nine approved drugs.
Summary for Sagent Pharms Inc
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 41 |
| NDAs: | 49 |
Drugs and US Patents for Sagent Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 207426-001 | Dec 8, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-002 | Dec 29, 2008 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-002 | Jul 18, 2011 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 091458-002 | Jul 28, 2010 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
